InFocus Therapeutics is developing technologies to attenuate “undruggable targets” by directly modulating RNA processes and functions, with the aim of treating cancers and neurodegenerative diseases. To this end, InFocus built an integrated computation-powered discovery platform to enable efficient decision-making in the discovery of RNA-targeting small molecule drugs.
Website →